通过表观遗传调节和免疫检查点抑制的组合,增强HBV特异性T细胞反应
Melanie Urbanek-Quaing1,2,3,4, Yin-Han Chou1,3,4,5, Manoj Kumar Gupta3,5
1Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
Hepatology (Baltimore, Md.)
|December 19, 2024
概括
德西他 (DAC) 和抗编程细胞死亡-1抗体 (αPD-L1) 的组合在体外增强了B型肝炎病毒 (HBV) 特定的T细胞反应. 这种方法可以通过逆转表观遗传变化,帮助恢复慢性HBV感染的免疫功能.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 慢性乙型肝炎病毒 (HBV) 感染导致T细胞耗尽和表观遗传改变,阻碍免疫反应.
- 标准免疫检查点抑制剂单疗法,如抗编程细胞死亡联体-1 (αPD-L1) 抗体,在恢复HBV特异性T细胞功能方面具有有限的有效性.
研究的目的:
- 为了调查DNA甲基转移酶抑制剂decitabine (DAC) 是否可以逆转慢性HBV感染中的表观遗传印记.
- 确定DAC是否可以增强αPD-L1在恢复HBV特异性T细胞反应中的有效性.
主要方法:
- 来自53名慢性HBV患者的外周血液单核细胞 (PBMC) 在体外用HBV刺激.
- 用流细胞计,临床数据,ex vivo DNA甲基化分析和血IFNγ水平来评估DAC/αPD-L1组合的免疫调节作用.
- 在22名HLA-A*02阳性患者中分析了HBV特定的CD8+T细胞反应.
主要成果:
- 在相当一部分患者中,DAC/αPD-L1组合显著增强了HBV特异性CD4+T细胞反应,而不管HBcrAg水平如何.
- 活体DNA甲基化分析揭示了DAC响应体中IFNG等基因的高甲基化,与改变的IFNγ血水平相关.
- 波尔455特异性CD8+ T细胞对DAC/αPD-L1的敏感性更大,表现优于αPD-L1单一治疗.
结论:
- DAC和αPD-L1的组合在体外显示了改善HBV特异性T细胞反应的潜力.
- 重塑与疲劳相关的表观遗传特征为HBV特异性T细胞恢复提供了一个有希望的策略.
- 这种组合代表了治疗慢性HBV感染的新型免疫治疗方法.
更多相关视频
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
2.9K
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
9.7K
相关概念视频
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Immune Response Against Viral Pathogens
745
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
745
Cytotoxic T Cells-mediated Immune Response
844
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
844
T Cell Activation and Clonal Selection
655
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
655
